Gri Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.10

+0.05 (+2.44%)

As of Sep 28, 10:47 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 5 83%

Hold 1 17%

Sell 0 0%

Price Target

Analyst Price Target +1,775.7% upside

Low Target $26.66

Average Target $39.39

High Target $54.88

Current Price $2.10

Current
$2.10

Target
$39.39

$26.66 $39.39 avg $54.88

Scenario Analysis

Bear Case

$26.66

1,169.5%

Low target

Base Case

$39.39

+1,775.7%

Avg target

Bull Case

$54.88

+2,513.3%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$64.12

-96.7% from high

52-Week Low

$1.36

+54.4% from low

Target vs 52W High

$39.39

-38.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%